Related references
Note: Only part of the references are listed.Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine
Benoit Baras et al.
PLOS ONE (2008)
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine:: a randomised controlled trial
Isabel Leroux-Roels et al.
LANCET (2007)
Avian influenza virus (H5N1): a threat to human health
J. S. Malik Peiris et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Three Indonesian clusters of H5N1 virus infection in 2005
I. Nyoman Kandun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial
Jiangtao Lin et al.
LANCET (2006)
Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets
Amorsolo L. Suguitan et al.
PLOS MEDICINE (2006)
Strategies for mitigating an influenza pandemic
Neil M. Ferguson et al.
NATURE (2006)
Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine:: phase I randomised trial
Jean-Louis Bresson et al.
LANCET (2006)
How prepared is Europe for pandemic influenza? Analysis of national plans
S Mounier-Jack et al.
LANCET (2006)
Mitigation strategies for pandemic influenza in the United States
TC Germann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine
JJ Treanor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Development and evaluation of influenza pandemic vaccines
I Stephenson et al.
LANCET INFECTIOUS DISEASES (2006)
Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/duck/Singapore/97 (H5N3) vaccine: A potential priming strategy
I Stephenson et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Probable person-to-person transmission of avian influenza A (H5N1)
K Ungchusak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines
RJ Webby et al.
LANCET (2004)